Why Your Caffeine Cutoff Might Need to Be Earlier Than Everyone Else's
Here's the starting point: cut caffeine by noon, or 2 PM at the latest. That's not an arbitrary number — it's grounded in how long caffeine actually stays active in your system and how sleep pressure builds across the day. But where you personally land inside that window, and how strict you actually need to be, depends on a few things most caffeine advice never accounts for: dysautonomia, MCAS, and where you are hormonally. This is why the same cutoff can feel like plenty of margin for one person and not nearly enough for another.
Why noonish, and why it's not the same for everyone
Caffeine works by blocking adenosine, the molecule that builds up in your brain across the day and creates the pressure to fall asleep. Block adenosine's signal, and sleep pressure doesn't register the way it should — which is the whole mechanism behind why caffeine keeps you alert (or really, just not-sleepy). Caffeine has an incredibly long half-life. A 2023 meta-analysis found that a typical cup of coffee (around 107mg) should be stopped at least 8.8 hours before bed in order to avoid sleep impacts — which is part of why noon-to-2pm lines up well with a typical evening bedtime. The other piece worth knowing: how sensitive any individual is to caffeine's effect on sleep varies substantially based on genetics — how fast your body metabolizes caffeine (via the CYP1A2 liver enzyme) and how sensitive your particular adenosine receptors are. So despite these general recommendations, the right cutoff for you may be worth testing.
That individual variability may be further complicated if you have dysautonomia. Dysautonomia International's clinical guidance notes plainly that some patients with dysautonomia feel better drinking caffeinated coffee regularly, others feel jittery or anxious and avoid it, and still others notice no effect at all — with no single mechanism or rule that predicts which group you're in. If you have a hyperadrenergic presentation of POTS, caffeine's stimulant effect on your already-elevated catecholamines may make palpitations or anxiety worse; if your orthostatic intolerance responds well to caffeine's mild vasoconstriction, it may genuinely help you get upright in the morning. Both are real, reported experiences, and neither is "wrong." Caffeine's mild diuretic effect can decrease blood volume, another reason to track its effects for you as an individual.
For MCAS, some people find coffee itself — separate from the caffeine — is a trigger, something a number of patients report anecdotally in relation to how coffee is fermented, roasted, or brewed rather than to caffeine content specifically. That's not settled science, but it's common enough to be worth noticing in your own case rather than assuming caffeine is either fine or off-limits across the board.
ADHD, which is more common in people with hypermobility, adds another layer here. ADHD involves dysregulated dopamine signaling, and the adenosine system — the same one caffeine blocks — helps modulate dopaminergic tone, which is part of why caffeine's effects on attention and alertness can look different in ADHD brains. In a study of almost 300 adolescents, those with ADHD were about 2.5 times more likely to drink caffeine in the afternoon or evening than their peers without ADHD, and evening caffeine use was linked to worse sleep specifically in the ADHD group.
And then there's hormones
Estrogen measurably slows how your body clears caffeine — one study found the elimination half-life of caffeine was roughly 47% longer in people using estrogen-containing oral contraceptives compared to those who weren't (7.88 hours versus 5.37 hours), and a separate study found estrogen replacement therapy has a similar inhibiting effect on caffeine metabolism in postmenopausal women. Perimenopause doesn't give you a stable estrogen level the way a contraceptive or replacement therapy does — yours is fluctuating, not elevated on a fixed schedule. That your caffeine "clock" may run slower on some days than others, purely because of where you are hormonally.
One note: a 2015 Mayo Clinic study found caffeine intake was associated with more severe hot flashes and night sweats in postmenopausal women — though the broader research on caffeine and vasomotor symptoms is genuinely mixed, with other studies finding the opposite association. That's a pattern worth watching in your own data rather than assuming either way.
What this means practically
Start with a caffeine cutoff at noon. If that feels unnecessarily restrictive — you're someone whose body handles caffeine well, your sleep isn't suffering, and 2pm still gives you a comfortable buffer before bed — you have some room to work with up to that later limit. But if you're dealing with hyperadrenergic POTS symptoms, a coffee-specific MCAS reaction, or you're in a stretch where estrogen is running high and your caffeine clearance is likely slower than usual, noon may still be too late, and pulling your cutoff earlier is worth testing rather than pushing through.
This is exactly where the symptom tracker you may already be building earns its keep: log your last caffeine time next to your sleep quality and cycle-phase notes for a couple of weeks, and you'll know whether noon is actually working for you or just feels fine in the moment. And if your usual dose runs higher than a single cup — a large coffee, an energy drink, a pre-workout supplement — the research above suggests you may need a meaningfully earlier cutoff than noon, not a later one.
If MCAS is part of your picture and you suspect coffee itself rather than caffeine, that's worth isolating separately — try a caffeine source without coffee's other compounds (tea, or a caffeine tablet) on a day you'd otherwise skip it, and see whether the reaction follows the caffeine or the coffee.
None of this is about eliminating caffeine. Noon-to-2pm is a solid, evidence-grounded place to start — the rest is about knowing whether your body needs you to hold that line tightly or gives you a little more room.
The bigger picture
The BENDY Method is a 12-week habit-based course for perimenopause and menopause in bodies with hEDS, HSD, MCAS, POTS, dysautonomia, and related presentations. Join the waitlist to be first to know when enrollment opens.
References
van Dam RM, Hu FB, Willett WC. Coffee, Caffeine, and Health. The New England Journal of Medicine. 2020;383(4):369-378.
Clark I, Landolt HP. Coffee, Caffeine, and Sleep: A Systematic Review of Epidemiological Studies and Randomized Controlled Trials. Sleep Medicine Reviews. 2017;31:70-78.
Gardiner C, Weakley J, Burke LM, et al. The Effect of Caffeine on Subsequent Sleep: A Systematic Review and Meta-Analysis. Sleep Medicine Reviews. 2023;69:101764.
Glans M, Thelin N, Humble MB, Elwin M, Bejerot S. Association Between Adult Attention-Deficit Hyperactivity Disorder and Generalised Joint Hypermobility: A Cross-Sectional Case Control Comparison. Journal of Psychiatric Research. 2021;143:334-340.
Kindgren E, Quiñones Perez A, Knez R. Prevalence of ADHD and Autism Spectrum Disorder in Children With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome: A Retrospective Study. Neuropsychiatric Disease and Treatment. 2021;17:379-388.
Valladão SC, França AP, Pandolfo P, Dos Santos-Rodrigues A. Adenosinergic System and Nucleoside Transporters in Attention Deficit Hyperactivity Disorder: Current Findings. Neuroscience and Biobehavioral Reviews. 2024;164:105771.
Cusick CN, Langberg JM, Breaux R, Green CD, Becker SP. Caffeine Use and Associations With Sleep in Adolescents With and Without ADHD. Journal of Pediatric Psychology. 2020;45(6):643-653.
Dysautonomia International. Principles of Autonomic Medicine: Managing Dysautonomias.
Mar PL, Raj SR. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies. Annual Review of Medicine. 2020;71:235-248.
Mathias CJ, Owens A, Iodice V, Hakim A. Dysautonomia in the Ehlers–Danlos Syndromes and Hypermobility Spectrum Disorders — With a Focus on the Postural Tachycardia Syndrome. American Journal of Medical Genetics Part C. 2021;187(4):510-519.
Abernethy DR, Todd EL. Impairment of Caffeine Clearance by Chronic Use of Low-Dose Oestrogen-Containing Oral Contraceptives. European Journal of Clinical Pharmacology. 1985;28(4):425-428.
Pollock BG, Wylie M, Stack JA, et al. Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women. Journal of Clinical Pharmacology. 1999;39(9):936-940.
Faubion SS, Sood R, Thielen JM, Shuster LT. Caffeine and Menopausal Symptoms: What Is the Association? Menopause. 2015;22(2):155-158.
Pimenta F, Leal I, Maroco J, Ramos C. Perceived Control, Lifestyle, Health, Socio-Demographic Factors and Menopause: Impact on Hot Flashes and Night Sweats. Maturitas. 2011;69(4):338-342.